Showing results (191-200 of 586) with videos related to

Sort By:
Pageof 59
Platelets|June 1, 2018
Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) studyWilliam A E Parker, Niclas Eriksson, Richard C Becker, et al.
American Heart Journal|December 19, 2015
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillationJulia Aulin, Agneta Siegbahn, Ziad Hijazi, et al.
Circulation|September 13, 2007
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndromeKai C Wollert, Tibor Kempf, Bo Lagerqvist, et al.
Heart (British Cardiac Society)|February 19, 2017
Effects of dabigatran according to age in atrial fibrillationMandy N Lauw, John W Eikelboom, Michiel Coppens, et al.
American Heart Journal|April 29, 2008
Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005Kevin Jackson, Bernard J Gersh, Norman Stockbridge, et al.
American Heart Journal|June 25, 2025
Rationale and design of a registry-based randomized controlled study of personalized biomarker-based risk score-guided stroke prevention treatment in atrial fibrillationZiad Hijazi, Lars Wallentin, Håkan Arheden, et al.
International Journal of Cardiology|September 25, 2023
Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndromeMaciej Olszowka, Emil Hagström, Nermin Hadziosmanovic, et al.
Journal of the American College of Cardiology|March 26, 2003
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudyStefan K James, Paul Armstrong, Elliott Barnathan, et al.
Circulation|August 30, 2025
Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled StudyJonas Oldgren, Ziad Hijazi, Håkan Arheden, et al.
The Lancet. Neurology|November 10, 2010
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trialHans-Christoph Diener, Stuart J Connolly, Michael D Ezekowitz, et al.
Pageof 59